Dudley Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Dudley Capital Management's PFE Position: Q3 2026 in Review
Dudley Capital Management increased its Pfizer (PFE) stake by 0.93% in Q3 2026, buying an estimated $16.8K and bringing the position to 68,722 shares worth $1.96M. The position accounts for 0.76% of the portfolio, ranked #32.
Dudley Capital Management first reported a position in PFE in Q4 2022 and has held it in 16 quarters since. The position peaked at $3.77M in Q4 2022. 1,391 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Dudley Capital Management held 68,722 shares of Pfizer worth $1.96M as of Q3 2026.
- Dudley Capital Management bought 632 Pfizer shares in Q3 2026, an estimated $16.8K.
- Pfizer made up 0.76% of Dudley Capital Management's portfolio in Q3 2026, its #32 holding.
- Dudley Capital Management first reported a position in Pfizer in Q4 2022 and has held it in 16 quarters since.
- Dudley Capital Management's Pfizer position peaked at $3.77M in Q4 2022.
- 1,391 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Dudley Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.